ATG5 and cancer: Employing the microRNA miR-183-5p to target ATG5 also enhances the radioresistance of CRC, and inhibiting autophagy through interfering with ATG5 may trigger cancer cell apoptosis by p53 activation, ER stress, and the UPR pathway.